We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Liquid Sensor Technology to Detect Cancer Instantly

By LabMedica International staff writers
Posted on 17 Mar 2010
It may be soon possible to go to the store and purchase a kit to diagnose cancer quickly and accurately, similar to a pregnancy test. More...
A researcher is developing a tiny sensor, known as an acoustic resonant sensor, smaller than a human hair that could test bodily fluids for a variety of diseases, including breast and prostate cancers.

"Many disease-related substances in liquids are not easily tracked,” said Dr. Jae Kwon, assistant professor of electrical and computer engineering at the University of Missouri (MU; Columbia, MO, USA). "In a liquid environment, most sensors experience a significant loss of signal quality, but by using highly sensitive, low-signal-loss acoustic resonant sensors in a liquid, these substances can be effectively and quickly detected--a brand-new concept that will result in a noninvasive approach for breast cancer detection.”

Dr. Kwon's real time, special acoustic resonant sensor uses micro/nanoelectromechanical systems (M/NEMS), which are tiny devices smaller than the diameter of a human hair, to detect directly diseases in body fluids. The sensor does not require bulky data reading or analyzing equipment and it can be integrated with equally small circuits, creating the potential for small stand-alone disease-screening systems. The sensor also produces fast, nearly immediate results that could reduce patient anxiety often felt after waiting for other detection methods, such as biopsies, which can take several days or weeks before results are known.

"Our ultimate goal is to produce a device that will simply and quickly diagnose multiple specific diseases, and eventually be used to create ‘point of care' systems, which are services provided to patients at their bedsides,” Dr. Kwon said. "The sensor has strong commercial potential to be manifested as simple home kits for easy, rapid, and accurate diagnosis of various diseases, such as breast cancer and prostate cancer.”

In January 2010, Kwon was awarded a US$400,000, five-year U.S. National Science (NSF) Foundation CAREER Award to continue his effort on this sensor research. The CAREER award is the NSF's most prestigious award in support of junior faculty members who exemplify the role of teacher-scholars through outstanding research, excellent teaching, and the integration of education and research.

Related Links:
University of Missouri


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.